Clinical studies recruiting near Kurralta Park

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · ICON Cancer Centre - Kurralta Park · Pfizer · NCT07028853 A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Phase 2 · ICON Kurralta Park · Verastem, Inc. · NCT07644559 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · ICON Cancer Centre - Kurralta Park · Eli Lilly and Company · NCT06890598 A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
Phase 1 · Icon Cancer Centre Kurralta Park · Janssen Research & Development, LLC · NCT05818683 A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 · ICON Cancer Centre Kurralta Park · MacroGenics · NCT06242470 A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif
Phase 2/Phase 3 · ICON Cancer Centre - Kurralta Park · Pfizer · NCT06989437 A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 i
Phase 3 · Icon Cancer Centre Kurralta Park · Incyte Corporation · NCT07284849 An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies
Phase 1 · Icon Cancer Centre Kurralta Park · BeOne Medicines · NCT07619287 Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for L
Phase 2/Phase 3 · Icon Cancer Centre Kurralta Park · BioNTech SE · NCT06712316 Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated S
Phase 3 · Icon Cancer Centre Kurralta Park · BioNTech SE · NCT06712355 A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Canc
Phase 3 · Icon Cancer Centre Kurralta Park · Janssen Research & Development, LLC · NCT07225946 A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants Wit
Phase 3 · ICON Cancer Centre - Kurralta Park · Celgene · NCT06764485 A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive,
Phase 3 · ICON Cancer Centre - Kurralta Park · Pfizer · NCT07062965 A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Phase 1 · Icon Cancer Centre Kurralta Park · BeOne Medicines · NCT05981703 A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer
Phase 1 · Jiangsu HengRui Medicine Co., Ltd. · NCT07711184 A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High
Phase 3 · Icon Cancer Centre Kurralta Park · Stemline Therapeutics, Inc. · NCT06492616 A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocy
Phase 2 · ICON Cancer Centre - Kurralta Park · Loxo Oncology, Inc. · NCT06588478 A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Phase 1/Phase 2 · Icon Cancer Centre Kurralta Park · Frontier Medicines Corporation · NCT06244771 Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
Phase 2 · ICON Cancer Centre - Kurralta Park · Pfizer · NCT05070845

Look up another city

Look up another condition